$EVFM this stock has been oscilating between $2.85 and $3.10 for the past 6+ weeks lol. Trade safe here guys and gals. Just because they have an FDA approved drug coming out in September doesn't mean the stock SP will rise significatnly by any means. This company had a Reverse Split a couple years ago before their Merger and they had a Dilutive Secondary offering several weeks ago to raise capital which sent the share price to sub $3. This company has screwed past shareholders and diluted them to the point where their investmnet has negative net returns. I've seen many biotechs with FDA approved drugs become Penny stocks with poor management. FYI when a properly run biotech recieves FDA approval the share price doesn't stay under $3. Way too many Red Flags here.
  • 4
  • 1
4 Likes